UCLA Health System

What UCLA Health System does

UCLA Health System is the clinical enterprise of the University of California, Los Angeles, operating as a state entity under The Regents of the University of California. It runs four major hospitals — Ronald Reagan UCLA Medical Center, UCLA Santa Monica Medical Center, UCLA Mattel Children's Hospital, and the Stewart and Lynda Resnick Neuropsychiatric Hospital — supported by more than 290 outpatient and immediate-care locations across Southern California. Its clinical portfolio spans oncology (Jonsson Comprehensive Cancer Center), neuroscience, transplant (including the world's first human bladder transplant in 2025), orthopedics and sports medicine, heart and vascular care, pediatrics, and behavioral health, with a Homeless Healthcare Collaborative serving street-medicine populations.

Revenue is generated primarily through clinical care services delivered to a broad patient base, supplemented by research funding (NIH grants of $1.72M and $9M cited among others), a $25.3M state grant for homeless healthcare, and large philanthropic gifts (including the $100M Resnick donation for mental health). Distribution is direct via the four hospitals, 290+ ambulatory sites, telehealth through the Epic MyChart-powered myUCLAhealth portal, and self-serve online appointment booking. Reach extends to international patients and to global health partnerships in India, Uganda, Zimbabwe, and Rwanda.

Technology assets include the INOVAi Center for AI safety and implementation evaluation, the proprietary SSPUL model for Alzheimer's detection from electronic health records, AI scribe pilots, a Salesforce Agentforce chatbot, and integration with Epic Care Everywhere for health information exchange. Strategic capital deployment includes the March 2025 acquisition of West Hills Hospital (now UCLA West Valley Medical Center), a 61% expansion of neuropsychiatric bed capacity, and entry into the Medicare Advantage market. Offsetting headwinds include approximately $200M in annual reductions tied to shrinking reimbursements.

Name

UCLA Health System

Legal name

The Regents of the University of California

Website

https://uclahealth.org

Company type

Private

Founded year

1951

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

UCLA Health System is a public academic health system operating four major hospitals and 290+ outpatient sites across Southern California, delivering oncology, neuroscience, transplant, cardiovascular, pediatric, and behavioral health services supported by the David Geffen School of Medicine and a national-leading research enterprise.

Ownership category

akta.pro rank

Product category

Academic Healthcare Services

NAICS

General Medical and Surgical Hospitals (622110), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Private/For-Profit Hospital Systems (HLAFAAAF)

akta.pro secondary industries

Children’s Hospitals & Pediatric Health Systems (HLAFAJAG), Inpatient Psychiatric Hospitals (HLAFAHAH), Inpatient Psychiatric Hospitals & Units (HLAFACAB)

Keywords

• Academic medical center
• Hospital and clinic network
• Cancer care services
• Transplant services
• Patient portal platform

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Care Services: UCLA Health generates revenue primarily through providing medical care services including hospital care, outpatient clinics, emergency services, surgical procedures, and specialty treatments across its network of hospitals and clinics throughout Southern California.
2. Research Grants and NIH Funding: UCLA Health receives substantial funding through NIH grants and research programs, including grants such as $1.72 million NIH grant for neuro-oncology training, $25.3 million for homeless healthcare, and $9 million for Parkinson's research.
3. Philanthropic Donations: UCLA Health receives major philanthropic gifts including the $100 million gift from Stewart and Lynda Resnick for mental health care expansion, and $2.4 million from Rose and Allen Nelson for neuroscience fellowship.
4. Medicare Advantage Plans: UCLA Health is developing its own Medicare Advantage insurance plan as a new revenue stream, following the trend of hospital systems creating their own health plans to address payment challenges with commercial insurers.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

UCLA Health System is an academic health system delivering comprehensive inpatient and outpatient clinical services through four major hospitals and 290+ outpatient locations across Southern California. Its core offerings span primary and specialty care, cancer treatment, organ transplantation (including pioneering bladder transplants), neuroscience, heart/vascular care, orthopedics, pediatrics, and psychiatry, supported by research, clinical trials, and digital tools such as the myUCLAhealth Epic patient portal and the INOVAi Center for AI evaluation in healthcare.

Product overview

UCLA Health System operates as a comprehensive academic health system offering a unified portfolio of clinical care, research, and digital health services. The core offering includes four major hospitals (Ronald Reagan UCLA Medical Center, UCLA Santa Monica Medical Center, Resnick Neuropsychiatric Hospital, Mattel Children's Hospital), over 290 outpatient locations, and specialized clinical services spanning cancer care, neuroscience, transplant, orthopedics, and heart/vascular care. Digital products include myUCLAhealth patient portal (powered by Epic MyChart) and the INOVAi Center for AI evaluation. The system also offers interpreter services, clinical trials participation, and virtual care/telehealth capabilities. Research collaborations include partnerships like the FloBiotech neurodegenerative disease therapeutics program.

Differentiator

Problem solved

Functional benefit

Brands

• INOVAi Center: Innovations and Outcomes Validation of AI Center - among the first programs in the nation focused specifically on evaluating AI safety and implementation in healthcare
• VITALS Conference

Products and services

• UCLA Health Hospitals & Clinics Network of hospitals and outpatient clinics including Ronald Reagan UCLA Medical Center, UCLA Santa Monica Medical Center, UCLA Resnick Neuropsychiatric Hospital, UCLA Mattel Children's Hospital, UCLA West Valley Medical Center, and 290+ outpatient locations across Southern California, providing acute care, primary care, specialty care, and surgical services to patients.
• myUCLAhealth Patient Portal Epic MyChart-based patient portal offering 24/7 personalized and secure online access to portions of patients' health information, enabling appointment scheduling, provider messaging, medical record access, and video visits, with two-factor authentication and proxy access for family members.
• Cancer Care (Jonsson Comprehensive Cancer Center) Comprehensive cancer center providing traditional treatments with clinical trials, immunotherapy, radioligand therapy, and specialized programs including Parker Institute for Cancer Immunotherapy Center designation.
• Transplant Services Advanced solid organ transplant care including groundbreaking bladder transplant procedures, liver and kidney transplants with exceptional patient outcomes, and clinical trials of immunosuppression-free approaches.
• Neuroscience Services Neurology and neurosurgery services advancing clinical care and research for brain tumors, neurodegenerative diseases including Alzheimer's and Parkinson's, and other neurological disorders, with active clinical trial enrollment.
• Orthopedics & Sports Medicine Full range of joint, bone, and muscle care from innovative therapies to advanced surgeries, serving athletes and active individuals, including dry powder inhaler and COPD management programs.
• Heart & Vascular Care Advanced cardiovascular care with new devices, treatments, and cutting-edge interventions for cardiovascular conditions including radioligand therapies and clinical trials.
• Stewart and Lynda Resnick Neuropsychiatric Hospital Specialized psychiatric hospital treating complex cases across all age groups including aggressive behavior in autistic children, eating disorders, and geriatric psychiatric care, with planned capacity expansion.
• UCLA West Valley Medical Center Acute care hospital in the San Fernando Valley acquired from West Hills Hospital & Medical Center, providing comprehensive medical services including emergency and inpatient care.
• Virtual Care / Telehealth Virtual care appointments and telehealth services enabling remote patient consultations, including MyChart Video Visits with interpreter services in multiple languages.
• Homeless Healthcare Collaborative Street Medicine Program Street medicine program providing outreach-based healthcare services, care coordination, and treatment continuity for homeless individuals across Los Angeles, supported by state grant funding.
• Language Services Interpreter services providing in-person, video conference, and telephone interpretation at no cost for all UCLA Health inpatients, outpatients, and their relatives, including Spanish staff interpreters and American Sign Language, plus website content in Arabic, Chinese, Italian, Japanese, Korean, Farsi, Russian, Spanish, and Vietnamese.
• International Patient Services Services supporting international patients seeking care at UCLA Health, including second opinion consults and care coordination for patients traveling from outside the United States.

Quantifiable outcome

• Bladder transplant patient reached full bladder capacity of 600ml by six months post-transplant
• +6 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature7 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• FloBiotechcoreStrategic or Co-development Partner · 9 June 2026FloBiotech announced an agreement with UCLA Health to develop therapeutics targeting neurodegenerative diseases, focusing on the compound DDL-357 which has shown promising results in preclinical models. The collaboration aims to leverage biological pathways to intervene earlier in disease progression and support multiple neurodegenerative indications. The partnership combines high-quality academic research with a scalable biotech pipeline, emphasizing early clinical validation and long-term impact.
• 93,936 Diverse Biobank ParticipantsminorOthersUCLA Health study published in Cell utilized genetic data and electronic health records from 93,936 participants in a diverse population biobank to identify links between genetics, disease risk, and medication response, with implications for personalized medicine concerning diabetes and weight loss drugs like semaglutide.
• Parker Institute for Cancer ImmunotherapycoreStrategic or Co-development PartnerUCLA Health Jonsson Comprehensive Cancer Center is a Parker Institute for Cancer Immunotherapy Center, collaborating on immunotherapy research and treatments including desmoplastic melanoma neoadjuvant immunotherapy trials.
• GRACE Program Partners (India, Uganda, Zimbabwe)minorStrategic or Co-development PartnerUCLA's Department of Obstetrics and Gynecology, through its GRACE program, has established global health partnerships with institutions in India, Uganda, and is planning a new initiative in Zimbabwe involving augmented reality technology. The collaboration with Medicine for Humanity in Uganda has established a regional fistula care center.
• GI Rising, Rwandan Society for Endoscopy, Rwanda Health MinistryminorStrategic or Co-development PartnerRwanda Endoscopy Week (REW) collaboration between US nonprofit GI Rising, the Rwandan Society for Endoscopy, the Rwanda Health Ministry, and Rwandan health facilities. Dr. Sean Nguyen from UCLA Health participated in 2025 program treating 1,069 patients at 10 sites across Rwanda.
• University of Pittsburgh Medical Center (UPMC)minorStrategic or Co-development PartnerResearchers at University of Pittsburgh Medical Center and UCLA reported clinical trial results showing that transplant recipients can be freed from lifelong immunosuppressant drugs through infusions of donor-derived regulatory cells. UCLA kidney trial produced positive results including one patient fully weaned after receiving a stem cell infusion.
• Cedars-Sinai Medical CenterminorStrategic or Co-development PartnerNational survey study led by UCLA Health and Cedars-Sinai Medical Center found significant disparities in how irritable bowel syndrome (IBS) is diagnosed across sex and racial groups in the U.S.
• Cedars-Sinai, University of Münster, University of DundeecoreStrategic or Co-development PartnerUCLA Health leads a $9 million, three-year research project funded by Aligning Science Across Parkinson's and The Michael J. Fox Foundation. Multi-institution study involves researchers from UCLA, Cedars-Sinai, University of Münster in Germany, and University of Dundee studying pesticides' and air pollution's link to Parkinson's disease.
• LuskinOICminorStrategic or Co-development PartnerLuskinOIC and the Center for Cerebral Palsy at UCLA co-host annual professional conference and family forum 'Cerebral Palsy Grows Up' bringing together medical professionals, people with cerebral palsy, and families.
• Orca BiominorStrategic or Co-development PartnerOrca Bio presented new clinical data at 2026 Tandem Meetings of ASTCT and CIBMTR reinforcing Orca-T as a durable, high-precision cell therapy for hematological malignancies, with UCLA Health mentioned as a clinical trial site.
• 22 Senior Women Healthcare ExecutivesminorOthersDiane L. Martin anthology 'Women in Health' featuring leadership insights from 22 senior women healthcare executives including UCLA Health contributions, documenting experiences navigating challenges and reshaping healthcare culture.

Scale indicators9 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Cedars-Sinai Medical Center: Cedars-Sinai is UCLA Health's closest direct competitor in the Los Angeles market — a major non-profit academic-affiliated health system with a flagship hospital, research enterprise, and overlapping specialty service lines (cancer, cardiology, neurosciences). The two systems already collaborate on regional research studies (e.g., IBS disparities), reflecting their market parity.
• Keck Medicine of USC: Keck Medicine is USC's academic health system and UCLA's primary direct competitor in the Los Angeles basin, with comparable hospital footprint, transplant and cancer services, and a similar academic-medical-center business model tied to a research university.
• Stanford Health Care: Stanford Health Care is a California-based academic health system comparable to UCLA in prestige, research intensity (NIH funding), and specialty-care depth — particularly in oncology, neurosciences, and transplant. Both serve as destination sites for complex cases within the western U.S.
• UCSF Health: UCSF Health is a sister University of California academic health system directly comparable to UCLA Health in scope, structure, and operating model — including a children's hospital, cancer center, psychiatric services, and primary/specialty care network. Like UCLA, UCSF combines clinical care, research, and education under a public university governance structure.

Broad incumbents

• NYU Langone Health: NYU Langone is a top-tier U.S. academic medical center with a comparable mix of hospital operations, NIH-funded research, AI/health-tech investment, and ambulatory expansion. It is one of the few systems nationally with similar scale, brand strength, and digital-health ambition to UCLA Health.
• Mass General Brigham: Mass General Brigham is a Harvard-affiliated integrated academic health system with national brand recognition, deep research funding, and a comparable service-line mix (cancer, neuroscience, transplant, psychiatry). Comparable to UCLA in scale, prestige, and the academic-medical-center operating model.
• Johns Hopkins Medicine: Johns Hopkins is the benchmark U.S. academic medical center with globally recognized research output and specialty care. Comparable to UCLA Health in its role as a top-tier research-intensive health system, particularly in oncology and neurosciences.
• Mount Sinai Health System: Mount Sinai is an NYC-based academic health system with a comparable mix of hospitals, research enterprise, specialty institutes (cancer, neurosciences), and ambulatory footprint. Comparable to UCLA in scale and academic-medical-center positioning.
• Northwestern Medicine: Northwestern Medicine is a major Midwestern academic health system anchored by a top-ranked medical school and research enterprise, with comparable specialty depth in oncology, cardiology, and neurosciences. Comparable to UCLA as a research-intensive, multi-hospital academic system.
• University of Pittsburgh Medical Center (UPMC): UPMC is one of the largest U.S. academic-affiliated health systems and a current UCLA research collaborator (transplant immunology / Orca-T cell therapy trials). Comparable to UCLA in scale, integration of insurance and provider assets, and academic-medical-center operating model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/UCLAHealth
• YouTubeyoutube.com/ucla-health
• Facebookfacebook.com/uclahealth
• LinkedInlinkedin.com/company/ucla-health
• Instagraminstagram.com/uclahealth

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries5 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UCLA Health System